Sign In

Login

Password

Forgot Password ? Sign Up

Cannabis als Rauschmittel (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cannabis als Rauschmittel" in German language version.

refsWebsite
Global rank German rank
95doi.org
2nd place
3rd place
68nih.gov
4th place
7th place
20zdb-katalog.de
123rd place
6th place
12web.archive.org
1st place
1st place
11redirecter.toolforge.org
33rd place
2nd place
6google.de
2,106th place
139th place
6who.int
195th place
255th place
5bundesgesundheitsministerium.de
low place
1,923rd place
5spiegel.de
66th place
4th place
3unodc.org
2,494th place
1,686th place
3tageblatt.lu
low place
1,894th place
3zeit.de
267th place
15th place
2cannabislegal.de
low place
low place
2drugcom.de
low place
8,424th place
2zdf.de
1,243rd place
75th place
2nature.com
234th place
203rd place
2elsevier.com
610th place
521st place
2bmg.gv.at
low place
low place
2bundestag.de
1,137th place
74th place
2tagesschau.de
884th place
51st place
1hanfmuseum.de
low place
low place
1pharmazeutische-zeitung.de
8,614th place
583rd place
1cannabis-med.org
low place
low place
1ahdictionary.com
2,334th place
4,401st place
1espacenet.com
800th place
160th place
1hellozurich.ch
low place
low place
1lagunatreatment.com
low place
low place
1ksta.de
2,437th place
172nd place
1stadt-zuerich.ch
9,227th place
1,203rd place
1wdr.de
1,513th place
90th place
1unc.edu
1,538th place
2,879th place
1europa.eu
68th place
29th place
1badscience.net
low place
low place
1drug-infopool.de
low place
low place
1psychologytoday.com
1,544th place
1,570th place
1ru.nl
9,179th place
8,661st place
1jamanetwork.com
2,650th place
1,472nd place
1drugabuse.gov
6,166th place
low place
1cancer.gov
1,684th place
7,111th place
1erowid.org
3,887th place
2,477th place
1spektrum.de
1,960th place
130th place
1books.google.com
3rd place
67th place
1aerzteblatt.de
3,043rd place
200th place
1unibe.ch
2,608th place
325th place
1reuters.com
49th place
151st place
1welt.de
201st place
11th place
1diepresse.com
1,466th place
97th place
1profil.at
9,468th place
679th place
1wa.gov
2,121st place
7,081st place
1uky.edu
3,273rd place
9,920th place
1dhs.de
low place
low place
1suchtmonitoring.ch
low place
low place
1tni.org
low place
low place
1sotomo.ch
low place
low place
1nationalarchives.gov.uk
744th place
1,384th place
1focus.de
460th place
28th place
1washingtonpost.com
34th place
113th place
1nhtsa.gov
7,538th place
3,706th place
1bundesverfassungsgericht.de
6,898th place
449th place
1verkehrslexikon.de
low place
4,530th place
1derstandard.de
4,051st place
264th place
1hanflegal.ch
low place
low place
1bfarm.de
low place
1,217th place
1taz.de
753rd place
43rd place
1waz.de
4,873rd place
306th place
1deutschlandfunkkultur.de
2,144th place
142nd place
1procon.org
low place
7,024th place
1filtermag.org
low place
low place
1thepresidency.gov.za
low place
low place
1marijuanamoment.net
low place
low place
1timesofmalta.com
2,301st place
2,454th place
1bangkokpost.com
1,173rd place
2,048th place
1wort.lu
6,385th place
988th place
1radio.cz
1,976th place
660th place
1expats.cz
low place
low place
1srf.ch
1,487th place
95th place
1freiburger-nachrichten.ch
low place
6,177th place
1weebly.com
1,195th place
1,801st place
1n-tv.de
1,071st place
60th place

aerzteblatt.de

cfcdn.aerzteblatt.de

ahdictionary.com

badscience.net

bangkokpost.com

bfarm.de

bmg.gv.at

books.google.com

bundesgesundheitsministerium.de

bundestag.de

bundesverfassungsgericht.de

cancer.gov

cannabis-med.org

cannabislegal.de

derstandard.de

deutschlandfunkkultur.de

dhs.de

  • Deutsche Hauptstelle für Suchtfragen e. V.: DHS Jahrbuch Sucht 2018. (PDF) Deutsche Hauptstelle für Suchtfragen e. V., 28. März 2018, abgerufen am 3. April 2018.

diepresse.com

  • Hanf: Der grüne Goldrausch in Österreich. In: Die Presse. (diepresse.com [abgerufen am 6. März 2018]).

doi.org

  • Hong-En Jiang, Xiao Li, You-Xing Zhao, David K. Ferguson, Francis Hueber, Subir Bera, Yu-Fei Wang, Liang-Cheng Zhao, Chang-Jiang Liu, Cheng-Sen Li: A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China. In: Journal of Ethnopharmacology, 108. Jg., Ausgabe 3, 6. Dezember 2006, S. 414–422, doi:10.1016/j.jep.2006.05.034.
  • Ethan B. Russo, Hong-En Jiang, Xiao Li, Alan Sutton, Andrea Carboni, Francesca del Bianco, Giuseppe Mandolino, David J. Potter, You-Xing Zhao, Subir Bera, Yong-Bing Zhang, En-Guo Lü, David K. Ferguson, Francis Hueber, Liang-Cheng Zhao, Chang-Jiang Liu, Yu-Fei Wang, Cheng-Sen Li: Phytochemical and genetic analyses of ancient cannabis from Central Asia. In: Journal of Experimental Botany. Band 59, Nr. 15, 1. November 2008, ISSN 0022-0957, S. 4171–4182, doi:10.1093/jxb/ern260 (englisch).
  • Ethan Russo: Cannabinoids as Therapeutics. Hrsg.: Raphael Mechoulam. Birkhäuser, Basel 2005, ISBN 978-3-7643-7055-8, Kapitel: Cannabis in India: ancient lore and modern medicine, S. 1–22, doi:10.1007/3-7643-7358-X_1.
  • D. Gloss: An Overview of Products and Bias in Research. In: Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. Band 12, Nummer 4, Oktober 2015, S. 731–734, doi:10.1007/s13311-015-0370-x, PMID 26202343, PMC 4604179 (freier Volltext) (Review).
  • Laura J. Rovetto, Niccolo V. Aieta: Supercritical carbon dioxide extraction of cannabinoids from Cannabis sativa L.. In: The Journal of Supercritical Fluids. 129, 2017, S. 16, doi:10.1016/j.supflu.2017.03.014.
  • C. P. Grof: Cannabis, from plant to pill. In: British journal of clinical pharmacology. Band 84, Nummer 11, November 2018, S. 2463–2467, doi:10.1111/bcp.13618, PMID 29701252, PMC 6177712 (freier Volltext) (Review).
  • Rosanna Smart, Jonathan P. Caulkins, Beau Kilmer, Steven Davenport, Greg Midgette: Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. In: Addiction. 112, 2017, S. 2167, doi:10.1111/add.13886.
  • M. A. ElSohly, Z. Mehmedic, S. Foster, C. Gon, S. Chandra, J. C. Church: Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States. In: Biological psychiatry. Band 79, Nummer 7, April 2016, S. 613–619, doi:10.1016/j.biopsych.2016.01.004, PMID 26903403, PMC 4987131 (freier Volltext).
  • T. R. Spindle, M. O. Bonn-Miller, R. Vandrey: Changing landscape of cannabis: novel products, formulations, and methods of administration. In: Current opinion in psychology. Band 30, 12 2019, S. 98–102, doi:10.1016/j.copsyc.2019.04.002, PMID 31071592, PMC 7041884 (freier Volltext) (Review).
  • S. Rom, Y. Persidsky: Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. In: Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology. Band 8, Nummer 3, Juni 2013, S. 608–620, doi:10.1007/s11481-013-9445-9, PMID 23471521, PMC 3663904 (freier Volltext) (Review).
  • Yehiel Gaoni, Raphael Mechoulam: Isolation, structure and partial synthesis of an active constituent of hashish. In: Journal of the American Chemical Society. Band 86, Nr. 8, 1964, S. 1646–1647, doi:10.1021/ja01062a046.
  • C. A. Paronis, S. P. Nikas, V. G. Shukla, A. Makriyannis: Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. In: Behavioural pharmacology. Band 23, Nummer 8, Dezember 2012, S. 802–805, ISSN 1473-5849. doi:10.1097/FBP.0b013e32835a7c4d. PMID 23075707. PMC 3697741 (freier Volltext).
  • Pertwee RG: The pharmacology of cannabinoid receptors and their ligands: An overview. In: International Journal of Obesity. 30. Jahrgang, 2006, S. S13–S18, doi:10.1038/sj.ijo.0803272, PMID 16570099.
  • Abir T. El-Alfy, Kelly Ivey, Keisha Robinson, Safwat Ahmed, Mohamed Radwan, Desmond Slade, Ikhlas Khan, Mahmoud Elsohly: Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. In: Pharmacology, Biochemistry and Behavior. 95. Jahrgang, Nr. 4, 2010, S. 434–42, doi:10.1016/j.pbb.2010.03.004, PMID 20332000, PMC 2866040 (freier Volltext).
  • P. Pacher, S. Bátkai, G. Kunos: The endocannabinoid system as an emerging target of pharmacotherapy. In: Pharmacological reviews. Band 58, Nummer 3, September 2006, S. 389–462, doi:10.1124/pr.58.3.2, PMID 16968947, PMC 2241751 (freier Volltext) (Review).
  • Fidelia Cascini, Carola Aiello, Gianluca Di Tanna: Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. In: Current Drug Abuse Reviews. Band 5, Nr. 1, 1. März 2012, S. 32–40, doi:10.2174/1874473711205010032, PMID 22150622.
  • Zerrin Atakan: Cannabis, a complex plant: different compounds and different effects on individuals. In: Therapeutic Advances in Psychopharmacology. Band 2, Nr. 6, 1. Dezember 2012, S. 241–254, doi:10.1177/2045125312457586, PMC 3736954 (freier Volltext).
  • Mauro Maccarrone, Manuel Guzmán, Ken Mackie, Patrick Doherty, Tibor Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature Reviews Neuroscience. Band 15, Nr. 12, Dezember 2014, ISSN 1471-003X, S. 786–801, doi:10.1038/nrn3846, PMID 25409697, PMC 4765324 (freier Volltext) – (nature.com [abgerufen am 3. August 2022]).
  • Miriam Schneider: Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure: Consequences of cannabis exposure dsuring puberty. In: Addiction Biology. Band 13, Nr. 2, Juni 2008, S. 253–263, doi:10.1111/j.1369-1600.2008.00110.x.
  • C McLaughlin: Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. In: Drug and Alcohol Dependence. Band 36, Nr. 1, August 1994, S. 27–31, doi:10.1016/0376-8716(94)90006-X.
  • Miriam Schneider: Adolescence as a vulnerable period to alter rodent behavior. In: Cell and Tissue Research. Band 354, Nr. 1, Oktober 2013, ISSN 0302-766X, S. 99–106, doi:10.1007/s00441-013-1581-2.
  • Heidi C. Meyer, Francis S. Lee, Dylan G. Gee: The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. In: Neuropsychopharmacology. Band 43, Nr. 1, Januar 2018, ISSN 0893-133X, S. 21–33, doi:10.1038/npp.2017.143, PMID 28685756, PMC 5719094 (freier Volltext).
  • Tibor Wenger, Ida Gerendai, Filomena Fezza, Sara González, Tiziana Bisogno: The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. In: Life Sciences. Band 70, Nr. 12, Februar 2002, S. 1407–1414, doi:10.1016/S0024-3205(01)01516-8.
  • Tibor Wenger, Dominique Croix, Gerard Tramu: The Effect of Chronic Prepubertal Administration of Marihuana (Delta-9-Tetrahydrocannabinol) on the Onset of Puberty and the Postpubertal Reproductive Functions in Female Rats. In: Biology of Reproduction. Band 39, Nr. 3, 1. Oktober 1988, ISSN 0006-3363, S. 540–545, doi:10.1095/biolreprod39.3.540.
  • Matthias Klugmann, Viktoria Klippenstein, F. Markus Leweke, Rainer Spanagel, Miriam Schneider: Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. In: The International Journal of Neuropsychopharmacology. Band 14, Nr. 04, Mai 2011, ISSN 1461-1457, S. 505–517, doi:10.1017/S1461145710001562.
  • The Journal of Neurosci. Society for Neuroscience, doi:10.1523/jneurosci.
  • Cannabis: Potenzial und Risiko. 2019, doi:10.1007/978-3-662-57291-7.
  • Samuel D. Banister, Jonathon C. Arnold, Mark Connor, Michelle Glass, Iain S. McGregor: Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol. In: ACS Chemical Neuroscience. 2019, doi:10.1021/acschemneuro.8b00651.
  • Zuzana Justinová, Sergi Ferré, Godfrey H. Redhi, Paola Mascia, Jessica Stroik, Davide Quarta, Sevil Yasar, Christa E. Müller, Rafael Franco, Steven R. Goldberg: Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. In: Addiction biology. Band 16, Nr. 3, 1. Juli 2011, S. 405–415, doi:10.1111/j.1369-1600.2010.00258.x, PMC 3115444 (freier Volltext).
  • A. M. Wycoff, J. Metrik, T. J. Trull: Affect and cannabis use in daily life: a review and recommendations for future research. In: Drug and alcohol dependence. Band 191, 10 2018, S. 223–233, doi:10.1016/j.drugalcdep.2018.07.001, PMID 30149283, PMC 6201696 (freier Volltext) (Review).
  • Clara Touriño, Andreas Zimmer, Olga Valverde, Dawn N. Albertson: THC Prevents MDMA Neurotoxicity in Mice. In: PLoS ONE. 5, 2010, S. e9143, doi:10.1371/journal.pone.0009143.
  • K. C. Morley, K. M. Li, G. E. Hunt, P. E. Mallet, I. S. McGregor: Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA („Ecstasy“) in rats. In: Neuropharmacology. Band 46, Nummer 7, Juni 2004, S. 954–965, doi:10.1016/j.neuropharm.2004.01.002. PMID 15081792.
  • G. J. Dumont, C. Kramers, F. C. Sweep, D. J. Touw, J. G. van Hasselt, M. de Kam, J. M. van Gerven, J. K. Buitelaar, R. J. Verkes: Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. In: Clinical pharmacology and therapeutics. Band 86, Nummer 2, August 2009, S. 160–166, doi:10.1038/clpt.2009.62. PMID 19440186, PDF, S. 121–138. (PDF; 2,6 MB) abgerufen am 23. Oktober 2015.
  • Diana L. Cichewicz: Synergistic interactions between cannabinoid and opioid analgesics. In: Life Sciences. Band 74, Nr. 11, 30. Januar 2004, S. 1317–1324, doi:10.1016/j.lfs.2003.09.038, PMID 14706563.
  • David J Nutt, Leslie A King, Lawrence D Phillips: Drug harms in the UK: a multicriteria decision analysis. In: The Lancet. 376, 2010, S. 1558–1565, doi:10.1016/S0140-6736(10)61462-6.
  • Mark J. Pletcher, Eric Vittinghoff, Ravi Kalhan, Joshua Richman, Monika Safford, Stephen Sidney, Feng Lin, Stefan Kertesz: Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. In: Journal of the American Medical Association. Band 307, Nr. 2, 11. Januar 2012, S. 173–181, doi:10.1001/jama.2011.1961 (englisch, jamanetwork.com).
  • M. Underner, T. Urban, J. Perriot, I. de Chazeron, J. C. Meurice: Cannabis smoking and lung cancer. In: Revue des maladies respiratoires. Band 31, Nummer 6, Juni 2014, S. 488–498, doi:10.1016/j.rmr.2013.12.002. PMID 25012035 (Review).
  • M. Joshi, A. Joshi, T. Bartter: Marijuana and lung diseases. In: Current opinion in pulmonary medicine. Band 20, Nummer 2, März 2014, S. 173–179, doi:10.1097/MCP.0000000000000026. PMID 24384575.
  • Russell C. Callaghan, Peter Allebeck, Anna Sidorchuk: Marijuana use and risk of lung cancer: a 40-year cohort study. In: Cancer Causes & Control. Band 24, Nr. 10, Oktober 2013, ISSN 0957-5243, S. 1811–1820, doi:10.1007/s10552-013-0259-0.
  • A. Hazekamp, R. Ruhaak, L. Zuurman, J. van Gerven, R. Verpoorte: Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. In: Journal of Pharmaceutical Sciences. Band 95, Nr. 6, Juni 2006, ISSN 0022-3549, S. 1308–1317, doi:10.1002/jps.20574, PMID 16637053 (englisch).
  • M. Joshi, A. Joshi, T. Bartter: Marijuana and lung diseases. In: Current opinion in pulmonary medicine. Band 20, Nr. 2, März 2014, S. 173–179, doi:10.1097/MCP.0000000000000026, PMID 24384575 (englisch, Übersichtsartikel).
  • J. R. Biehl, E. L. Burnham: Cannabis Smoking in 2015: A Concern for Lung Health? In: Chest. Band 148, Nummer 3, September 2015, S. 596–606, doi:10.1378/chest.15-0447, PMID 25996274, PMC 4556119 (freier Volltext) (Review).
  • B. Misiak, F. Stramecki, Gawęda, K. Prochwicz, M. M. Sąsiadek, A. A. Moustafa, D. Fryd: Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review. In: Molecular neurobiology. Band 55, Nummer 6, Juni 2018, S. 5075–5100, doi:10.1007/s12035-017-0708-y, PMID 28822116, PMC 5948257 (freier Volltext) (Review).
  • T. H. Moore, S. Zammit, A. Lingford-Hughes, T. R. Barnes, P. B. Jones, M. Burke, G. Lewis: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. In: Lancet. Band 370, Nummer 9584, Juli 2007, S. 319–328, doi:10.1016/S0140-6736(07)61162-3, PMID 17662880 (Review).
  • J. A. McLaren, E. Silins, D. Hutchinson, R. P. Mattick, W. Hall: Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. In: The International journal on drug policy. Band 21, Nummer 1, Januar 2010, S. 10–19, doi:10.1016/j.drugpo.2009.09.001, PMID 19783132 (Review).
  • S. Minozzi, M. Davoli, A. M. Bargagli, L. Amato, S. Vecchi, C. A. Perucci: An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. In: Drug and alcohol review. Band 29, Nummer 3, Mai 2010, S. 304–317, doi:10.1111/j.1465-3362.2009.00132.x, PMID 20565524 (Review).
  • M. Di Forti, D. Quattrone u. a.: The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. In: The lancet. Psychiatry. [elektronische Veröffentlichung vor dem Druck] März 2019, doi:10.1016/S2215-0366(19)30048-3, PMID 30902669 (freier Volltext).
  • R. Kuepper, P. D. Morrison, J. van Os, R. M. Murray, G. Kenis, C. Henquet: Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. In: Schizophrenia research. Band 121, Nummer 1–3, August 2010, S. 107–117, doi:10.1016/j.schres.2010.05.031, PMID 20580531 (Review).
  • Musa Basser Sami, Eugenii A. Rabiner, Sagnik Bhattacharyya: Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. In: European Neuropsychopharmacology. 25, 2015, S. 1201, doi:10.1016/j.euroneuro.2015.03.011.
  • Laura C. Andreae: Cannabis use and schizophrenia: Chicken or egg?. In: Science Translational Medicine. 10, 2018, S. eaav0342, doi:10.1126/scitranslmed.aav0342.
  • Martin Frisher, Ilana Crome, Orsolina Martino, Peter Croft: Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. In: Schizophrenia Research. 113, 2009, S. 123, doi:10.1016/j.schres.2009.05.031.
  • H. Bugra, C. Rapp, E. Studerus, J. Aston, S. Borgwardt, A. Riecher-Rössler: Kann Cannabis das Risiko für schizophrene Psychosen erhöhen? In: Fortschritte der Neurologie · Psychiatrie. Band 80, Nr. 11, 1. November 2012, S. 635–643, doi:10.1055/s-0032-1325415.
  • Heekeren: Führt Cannabiskonsum zu Schizophrenie? In: PRAXIS. Band 100, Nr. 22, 1. November 2011, S. 1361–1367, doi:10.1024/1661-8157/a000714.
  • David M. Semple, Andrew M. McIntosh, Stephen M. Lawrie: Cannabis as a risk factor for psychosis: systematic review. In: Journal of Psychopharmacology. Band 19, Nr. 2, 1. März 2005, S. 187–194, doi:10.1177/0269881105049040.
  • J. Vaucher, B. J. Keating, A. M. Lasserre, W. Gan, D. M. Lyall, J. Ward, D. J. Smith, J. P. Pell, N. Sattar, G. Paré, M. V. Holmes: Cannabis use and risk of schizophrenia: a Mendelian randomization study. In: Molecular psychiatry. [elektronische Veröffentlichung vor dem Druck] Januar 2017, doi:10.1038/mp.2016.252, PMID 28115737, online (abgerufen am 4. Juli 2017).
  • J. Zheng, D. Baird, M. C. Borges, J. Bowden, G. Hemani, P. Haycock, D. M. Evans, G. D. Smith: Recent Developments in Mendelian Randomization Studies. In: Current epidemiology reports. Band 4, Nummer 4, 2017, S. 330–345, doi:10.1007/s40471-017-0128-6, PMID 29226067, PMC 5711966 (freier Volltext) (Review).
  • J. A. Pasman, K. J. Verweij u. a.: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. In: Nature Neuroscience. Band 21, Nummer 9, September 2018, S. 1161–1170, doi:10.1038/s41593-018-0206-1, PMID 30150663, PMC 6386176 (freier Volltext).
  • E. Hoch, U. Bonnet, R. Thomasius, F. Ganzer, U. Havemann-Reinecke, U. W. Preuss: Risks associated with the non-medicinal use of cannabis. In: Deutsches Ärzteblatt international. Band 112, Nr. 16, April 2015, S. 271–278, doi:10.3238/arztebl.2015.0271, PMID 25939318, PMC 4442549 (freier Volltext) – (Online-Version auf Deutsch: Risiken bei nichtmedizinischem Gebrauch von Cannabis [abgerufen am 5. Juni 2022] Übersichtsartikel).
  • I. Pacheco-Colón, J. M. Limia, R. Gonzalez: Nonacute effects of cannabis use on motivation and reward sensitivity in humans: A systematic review. In: Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. Band 32, Nummer 5, 08 2018, S. 497–507, doi:10.1037/adb0000380, PMID 29963875, PMC 6062456 (freier Volltext).
  • K. R. Hefner, M. J. Starr, J. J. Curtin: Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty. In: Journal of abnormal psychology. Band 125, Nummer 1, Januar 2016, S. 138–150, doi:10.1037/abn0000106, PMID 26595464, PMC 4701603 (freier Volltext).
  • E. van de Giessen, J. J. Weinstein, C. M. Cassidy, M. Haney, Z. Dong, R. Ghazzaoui, N. Ojeil, L. S. Kegeles, X. Xu, N. P. Vadhan, N. D. Volkow, M. Slifstein, A. Abi-Dargham: Deficits in striatal dopamine release in cannabis dependence. In: Molecular psychiatry. [elektronische Veröffentlichung vor dem Druck] März 2016, doi:10.1038/mp.2016.21, PMID 27001613.
  • M. A. Bloomfield, A. H. Ashok, N. D. Volkow, O. D. Howes: The effects of Δ(9)-tetrahydrocannabinol on the dopamine system. In: Nature. Band 539, Nummer 7629, 11 2016, S. 369–377, doi:10.1038/nature20153, PMID 27853201, PMC 5123717 (freier Volltext) (Review).
  • Review in: M. A. Bloomfield, C. J. Morgan, A. Egerton, S. Kapur, H. V. Curran, O. D. Howes: Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. In: Biological psychiatry. Band 75, Nummer 6, März 2014, S. 470–478, doi:10.1016/j.biopsych.2013.05.027, PMID 23820822 (freier Volltext unter DOI-Link).
  • J. Jacobus, D. Goldenberg, C. E. Wierenga, N. J. Tolentino, T. T. Liu, S. F. Tapert: Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. In: Psychopharmacology. Band 222, Nummer 4, August 2012, S. 675–684, doi:10.1007/s00213-012-2674-4, PMID 22395430, PMC 3510003 (freier Volltext).
  • M. Rocchetti, A. Crescini, S. Borgwardt, E. Caverzasi, P. Politi, Z. Atakan, P. Fusar-Poli: Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. In: Psychiatry and clinical neurosciences. Band 67, Nummer 7, November 2013, S. 483–492, doi:10.1111/pcn.12085, PMID 24118193 (Review).
  • M. Maccarrone, M. Guzmán, K. Mackie, P. Doherty, T. Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature reviews. Neuroscience. Band 15, Nummer 12, Dezember 2014, S. 786–801, doi:10.1038/nrn3846, PMID 25409697 (Review).
  • P. Campolongo, V. Trezza, M. Palmery, L. Trabace, V. Cuomo: Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. In: International review of neurobiology. Band 85, 2009, S. 117–133, doi:10.1016/S0074-7742(09)85009-5, PMID 19607965 (Review).
  • S. Anavi-Goffer, J. Mulder: The polarised life of the endocannabinoid system in CNS development. In: Chembiochem: a European journal of chemical biology. Band 10, Nummer 10, Juli 2009, S. 1591–1598, doi:10.1002/cbic.200800827, PMID 19533710 (Review).
  • D. I. Lubman, A. Cheetham, M. Yücel: Cannabis and adolescent brain development. In: Pharmacology & therapeutics. Band 148, April 2015, S. 1–16, doi:10.1016/j.pharmthera.2014.11.009, PMID 25460036 (Review).
  • B. Chadwick, M. L. Miller, Y. L. Hurd: Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. In: Frontiers in psychiatry. Band 4, 2013, S. 129, doi:10.3389/fpsyt.2013.00129, PMID 24133461, PMC 3796318 (freier Volltext) (Review).
  • D. T. Malone, M. N. Hill, T. Rubino: Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. In: British journal of pharmacology. Band 160, Nummer 3, Juni 2010, S. 511–522, doi:10.1111/j.1476-5381.2010.00721.x, PMID 20590561, PMC 2931552 (freier Volltext) (Review).
  • N. Realini, T. Rubino, D. Parolaro: Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. In: Pharmacological research: the official journal of the Italian Pharmacological Society. Band 60, Nummer 2, August 2009, S. 132–138, doi:10.1016/j.phrs.2009.03.006, PMID 19559364 (Review).
  • J Hirvonen, RS Goodwin, C-T Li, GE Terry, SS Zoghbi: Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. In: Molecular Psychiatry. Band 17, Nr. 6, Juni 2012, ISSN 1359-4184, S. 642–649, doi:10.1038/mp.2011.82, PMID 21747398, PMC 3223558 (freier Volltext).
  • S. J. Broyd, H. H. van Hell, C. Beale, M. Yücel, N. Solowij: Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. In: Biological psychiatry. Band 79, Nummer 7, April 2016, S. 557–567, doi:10.1016/j.biopsych.2015.12.002, PMID 26858214 (Review).
  • M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts, R. S. Keefe, K. McDonald, A. Ward, R. Poulton, T. E. Moffitt: Persistent cannabis users show neuropsychological decline from childhood to midlife. In: Proceedings of the National Academy of Sciences. Band 109, Nummer 40, Oktober 2012, S. E2657–E2664, doi:10.1073/pnas.1206820109, PMID 22927402, PMC 3479587 (freier Volltext).
  • J. C. Scott, S. T. Slomiak, J. D. Jones, A. F. Rosen, T. M. Moore, R. C. Gur: Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis. In: JAMA psychiatry. Band 75, Nummer 6, Juni 2018, S. 585–595, doi:10.1001/jamapsychiatry.2018.0335, PMID 29710074, PMC 6137521 (freier Volltext).
  • L. Kloft, H. Otgaar, A. Blokland, L. A. Monds, S. W. Toennes, E. F. Loftus, J. G. Ramaekers: Cannabis increases susceptibility to false memory. In: Proceedings of the National Academy of Sciences. Band 117, Nummer 9, März 2020, S. 4585–4589, doi:10.1073/pnas.1920162117, PMID 32041881, PMC 7060677 (freier Volltext).
  • J. G. Ramaekers, N. L. Mason, L. Kloft, E. L. Theunissen: The why behind the high: determinants of neurocognition during acute cannabis exposure. In: Nature reviews. Neuroscience. Band 22, Nummer 7, Juli 2021, S. 439–454, doi:10.1038/s41583-021-00466-4, PMID 34045693 (Review).
  • E. B. Oleson, J. F. Cheer: A brain on cannabinoids: the role of dopamine release in reward seeking. In: Cold Spring Harbor perspectives in medicine. Band 2, Nr. 8, 2012, S. 1–13, doi:10.1101/cshperspect.a012229, PMID 22908200, PMC 3405830 (freier Volltext) – (englisch, Übersichtsartikel).
  • E. van de Giessen, J. J. Weinstein, C. M. Cassidy, M. Haney, Z. Dong, R. Ghazzaoui, N. Ojeil, L. S. Kegeles, X. Xu, N. P. Vadhan, N. D. Volkow, M. Slifstein, A. Abi-Dargham: Deficits in striatal dopamine release in cannabis dependence. In: Molecular Psychiatry. Band 22, Nr. 1, Januar 2017, S. 68–75, doi:10.1038/mp.2016.21, PMID 27001613, PMC 5033654 (freier Volltext) – (elektronische Veröffentlichung vor dem Druck, März 2016).
  • D. R. ENGLISH, G. K. HULSE, E. MILNE, C. D. J. HOLMAN, C. I. BOWER: Maternal cannabis use and birth weight: a meta-analysis. In: Addiction. Band 92, Nr. 11, November 1997, ISSN 0965-2140, S. 1553–1560, doi:10.1111/j.1360-0443.1997.tb02875.x.
  • Shalem Y. Leemaqz, Gustaaf A. Dekker, Lesley M. McCowan, Louise C. Kenny, Jenny E. Myers: Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. In: Reproductive Toxicology. Band 62, Juli 2016, ISSN 0890-6238, S. 77–86, doi:10.1016/j.reprotox.2016.04.021.
  • J Bailey: Fetal disposition of ?9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. In: Toxicology and Applied Pharmacology. Band 90, Nr. 2, September 1987, S. 315–321, doi:10.1016/0041-008X(87)90338-3 (elsevier.com [abgerufen am 3. August 2022]).
  • P.A. Fried: the ottawa prenatal prospective study (OPPS): Methodological issues and findings — it's easy to throw the baby out with the bath water. In: Life Sciences. Band 56, Nr. 23-24, Mai 1995, S. 2159–2168, doi:10.1016/0024-3205(95)00203-I (elsevier.com [abgerufen am 3. August 2022]).
  • Albert Stuart Reece: Chronic toxicology of cannabis. In: Clinical Toxicology. Band 47, Nr. 6, Juli 2009, ISSN 1556-3650, S. 517–524, doi:10.1080/15563650903074507.
  • Tina Birk Irner: Substance exposure in utero and developmental consequences in adolescence: A systematic review. In: Child Neuropsychology. Band 18, Nr. 6, November 2012, ISSN 0929-7049, S. 521–549, doi:10.1080/09297049.2011.628309.
  • Justin H. G. Williams, Louise Ross: Consequences of prenatal toxin exposure for mental health in children and adolescents: A systematic review. In: European Child & Adolescent Psychiatry. Band 16, Nr. 4, Juni 2007, ISSN 1018-8827, S. 243–253, doi:10.1007/s00787-006-0596-6.
  • P.A. Fried: the ottawa prenatal prospective study (OPPS): Methodological issues and findings — it's easy to throw the baby out with the bath water. In: Life Sciences. Band 56, Nr. 23-24, Mai 1995, S. 2159–2168, doi:10.1016/0024-3205(95)00203-I.
  • Eva Hoch, Miriam Schneider, Chris Maria Friemel (Hrsg.): Cannabis: Potenzial und Risiko - Eine wissenschaftliche Bestandsaufnahme. Springer, Heidelberg 2019, ISBN 978-3-662-57291-7, doi:10.1007/978-3-662-57291-7 (478 S., bundesgesundheitsministerium.de [PDF]). siehe Seite 57, 2.7 Limitationen.
  • M. L. Miller, Y. L. Hurd: Testing the Gateway Hypothesis. In: Neuropsychopharmacology. Band 42, Nummer 5, 04 2017, S. 985–986, doi:10.1038/npp.2016.279, PMID 28096528, PMC 5506797 (freier Volltext).
  • Orrin Devinsky, Maria R. Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William G. Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley, Daniel Friedman: Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. In: Epilepsia. Band 55, Nr. 6, 1. Juni 2014, S. 791–802, doi:10.1111/epi.12631, PMC 4707667 (freier Volltext).
  • Tom P. Freeman, Teodora Groshkova, Andrew Cunningham, Roumen Sedefov, Paul Griffiths, Michael T. Lynskey: Increasing potency and price of cannabis in Europe, 2006–16. In: Addiction. Wiley Online Library, doi:10.1111/add.14525.
  • C. Donath, D. Baier, E. Graessel, T. Hillemacher: Substance consumption in adolescents with and without an immigration background: a representative study—What part of an immigration background is protective against binge drinking? In: BMC Public Health. Band 16, 2016, S. 1157, doi:10.1186/s12889-016-3796-0, PMID 27842534.
  • Franjo Grotenhermen: Fahrtüchtigkeit, Fahreignung und Cannabiskonsum. 26. März 1999, doi:10.1007/978-3-642-56070-5_9.
  • Franziska Busse, Leyla Omidi, Alexander Leichtle, Michael Windgassen, Eyleen Kluge, Michael Stumvoll: Lead Poisoning Due to Adulterated Marijuana. In: New England Journal of Medicine. Band 358, Nr. 15, 10. April 2008, S. 1641–1642, doi:10.1056/NEJMc0707784, PMC 2696942 (freier Volltext).

drug-infopool.de

drugabuse.gov

drugcom.de

elsevier.com

linkinghub.elsevier.com

  • J Bailey: Fetal disposition of ?9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. In: Toxicology and Applied Pharmacology. Band 90, Nr. 2, September 1987, S. 315–321, doi:10.1016/0041-008X(87)90338-3 (elsevier.com [abgerufen am 3. August 2022]).
  • P.A. Fried: the ottawa prenatal prospective study (OPPS): Methodological issues and findings — it's easy to throw the baby out with the bath water. In: Life Sciences. Band 56, Nr. 23-24, Mai 1995, S. 2159–2168, doi:10.1016/0024-3205(95)00203-I (elsevier.com [abgerufen am 3. August 2022]).

erowid.org

espacenet.com

worldwide.espacenet.com

  • Patentanmeldung US2017197217A1: Dual Purpose Female Cannabis Seedless Flower Bud Trimmers, Kief Separators and Methods. Angemeldet am 25. März 2017, veröffentlicht am 13. Juli 2017, Erfinder: Thomas Bruggemann.‌

europa.eu

emcdda.europa.eu

expats.cz

filtermag.org

focus.de

freiburger-nachrichten.ch

google.de

books.google.de

hanflegal.ch

hanfmuseum.de

hellozurich.ch

jamanetwork.com

jama.jamanetwork.com

  • Mark J. Pletcher, Eric Vittinghoff, Ravi Kalhan, Joshua Richman, Monika Safford, Stephen Sidney, Feng Lin, Stefan Kertesz: Association Between Marijuana Exposure and Pulmonary Function Over 20 Years. In: Journal of the American Medical Association. Band 307, Nr. 2, 11. Januar 2012, S. 173–181, doi:10.1001/jama.2011.1961 (englisch, jamanetwork.com).

ksta.de

lagunatreatment.com

marijuanamoment.net

n-tv.de

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

nature.com

  • Mauro Maccarrone, Manuel Guzmán, Ken Mackie, Patrick Doherty, Tibor Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature Reviews Neuroscience. Band 15, Nr. 12, Dezember 2014, ISSN 1471-003X, S. 786–801, doi:10.1038/nrn3846, PMID 25409697, PMC 4765324 (freier Volltext) – (nature.com [abgerufen am 3. August 2022]).
  • J. Vaucher, B. J. Keating, A. M. Lasserre, W. Gan, D. M. Lyall, J. Ward, D. J. Smith, J. P. Pell, N. Sattar, G. Paré, M. V. Holmes: Cannabis use and risk of schizophrenia: a Mendelian randomization study. In: Molecular psychiatry. [elektronische Veröffentlichung vor dem Druck] Januar 2017, doi:10.1038/mp.2016.252, PMID 28115737, online (abgerufen am 4. Juli 2017).

nhtsa.gov

  • R. Compton, A. Berning: Drug and Alcohol Crash Risk. In: Traffic Safety Facts. Department of Transportation’s National Highway Traffic Safety Administration, Februar 2015 (nhtsa.gov [PDF; abgerufen am 20. Februar 2015]).

nih.gov

ncbi.nlm.nih.gov

  • D. Gloss: An Overview of Products and Bias in Research. In: Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. Band 12, Nummer 4, Oktober 2015, S. 731–734, doi:10.1007/s13311-015-0370-x, PMID 26202343, PMC 4604179 (freier Volltext) (Review).
  • C. P. Grof: Cannabis, from plant to pill. In: British journal of clinical pharmacology. Band 84, Nummer 11, November 2018, S. 2463–2467, doi:10.1111/bcp.13618, PMID 29701252, PMC 6177712 (freier Volltext) (Review).
  • M. A. ElSohly, Z. Mehmedic, S. Foster, C. Gon, S. Chandra, J. C. Church: Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States. In: Biological psychiatry. Band 79, Nummer 7, April 2016, S. 613–619, doi:10.1016/j.biopsych.2016.01.004, PMID 26903403, PMC 4987131 (freier Volltext).
  • T. R. Spindle, M. O. Bonn-Miller, R. Vandrey: Changing landscape of cannabis: novel products, formulations, and methods of administration. In: Current opinion in psychology. Band 30, 12 2019, S. 98–102, doi:10.1016/j.copsyc.2019.04.002, PMID 31071592, PMC 7041884 (freier Volltext) (Review).
  • S. Rom, Y. Persidsky: Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. In: Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology. Band 8, Nummer 3, Juni 2013, S. 608–620, doi:10.1007/s11481-013-9445-9, PMID 23471521, PMC 3663904 (freier Volltext) (Review).
  • C. A. Paronis, S. P. Nikas, V. G. Shukla, A. Makriyannis: Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. In: Behavioural pharmacology. Band 23, Nummer 8, Dezember 2012, S. 802–805, ISSN 1473-5849. doi:10.1097/FBP.0b013e32835a7c4d. PMID 23075707. PMC 3697741 (freier Volltext).
  • Pertwee RG: The pharmacology of cannabinoid receptors and their ligands: An overview. In: International Journal of Obesity. 30. Jahrgang, 2006, S. S13–S18, doi:10.1038/sj.ijo.0803272, PMID 16570099.
  • Abir T. El-Alfy, Kelly Ivey, Keisha Robinson, Safwat Ahmed, Mohamed Radwan, Desmond Slade, Ikhlas Khan, Mahmoud Elsohly: Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. In: Pharmacology, Biochemistry and Behavior. 95. Jahrgang, Nr. 4, 2010, S. 434–42, doi:10.1016/j.pbb.2010.03.004, PMID 20332000, PMC 2866040 (freier Volltext).
  • E. P. de Meijer, M. Bagatta, A. Carboni, P. Crucitti, V. M. Moliterni, P. Ranalli, G. Mandolino: The inheritance of chemical phenotype in Cannabis sativa L. In: Genetics. Band 163, Nummer 1, Januar 2003, S. 335–346, PMID 12586720, PMC 1462421 (freier Volltext).
  • McCallum ND, Yagen B, Levy S, Mechoulam R: Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol In: Experientia . Band 31, Nummer 5, Mai 1975, S. 520–521, PMID 1140243.
  • P. Pacher, S. Bátkai, G. Kunos: The endocannabinoid system as an emerging target of pharmacotherapy. In: Pharmacological reviews. Band 58, Nummer 3, September 2006, S. 389–462, doi:10.1124/pr.58.3.2, PMID 16968947, PMC 2241751 (freier Volltext) (Review).
  • Fidelia Cascini, Carola Aiello, Gianluca Di Tanna: Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. In: Current Drug Abuse Reviews. Band 5, Nr. 1, 1. März 2012, S. 32–40, doi:10.2174/1874473711205010032, PMID 22150622.
  • Zerrin Atakan: Cannabis, a complex plant: different compounds and different effects on individuals. In: Therapeutic Advances in Psychopharmacology. Band 2, Nr. 6, 1. Dezember 2012, S. 241–254, doi:10.1177/2045125312457586, PMC 3736954 (freier Volltext).
  • Mauro Maccarrone, Manuel Guzmán, Ken Mackie, Patrick Doherty, Tibor Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature Reviews Neuroscience. Band 15, Nr. 12, Dezember 2014, ISSN 1471-003X, S. 786–801, doi:10.1038/nrn3846, PMID 25409697, PMC 4765324 (freier Volltext) – (nature.com [abgerufen am 3. August 2022]).
  • Heidi C. Meyer, Francis S. Lee, Dylan G. Gee: The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. In: Neuropsychopharmacology. Band 43, Nr. 1, Januar 2018, ISSN 0893-133X, S. 21–33, doi:10.1038/npp.2017.143, PMID 28685756, PMC 5719094 (freier Volltext).
  • Zuzana Justinová, Sergi Ferré, Godfrey H. Redhi, Paola Mascia, Jessica Stroik, Davide Quarta, Sevil Yasar, Christa E. Müller, Rafael Franco, Steven R. Goldberg: Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. In: Addiction biology. Band 16, Nr. 3, 1. Juli 2011, S. 405–415, doi:10.1111/j.1369-1600.2010.00258.x, PMC 3115444 (freier Volltext).
  • A. M. Wycoff, J. Metrik, T. J. Trull: Affect and cannabis use in daily life: a review and recommendations for future research. In: Drug and alcohol dependence. Band 191, 10 2018, S. 223–233, doi:10.1016/j.drugalcdep.2018.07.001, PMID 30149283, PMC 6201696 (freier Volltext) (Review).
  • K. C. Morley, K. M. Li, G. E. Hunt, P. E. Mallet, I. S. McGregor: Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA („Ecstasy“) in rats. In: Neuropharmacology. Band 46, Nummer 7, Juni 2004, S. 954–965, doi:10.1016/j.neuropharm.2004.01.002. PMID 15081792.
  • G. J. Dumont, C. Kramers, F. C. Sweep, D. J. Touw, J. G. van Hasselt, M. de Kam, J. M. van Gerven, J. K. Buitelaar, R. J. Verkes: Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. In: Clinical pharmacology and therapeutics. Band 86, Nummer 2, August 2009, S. 160–166, doi:10.1038/clpt.2009.62. PMID 19440186, PDF, S. 121–138. (PDF; 2,6 MB) abgerufen am 23. Oktober 2015.
  • Diana L. Cichewicz: Synergistic interactions between cannabinoid and opioid analgesics. In: Life Sciences. Band 74, Nr. 11, 30. Januar 2004, S. 1317–1324, doi:10.1016/j.lfs.2003.09.038, PMID 14706563.
  • M. Underner, T. Urban, J. Perriot, I. de Chazeron, J. C. Meurice: Cannabis smoking and lung cancer. In: Revue des maladies respiratoires. Band 31, Nummer 6, Juni 2014, S. 488–498, doi:10.1016/j.rmr.2013.12.002. PMID 25012035 (Review).
  • M. Joshi, A. Joshi, T. Bartter: Marijuana and lung diseases. In: Current opinion in pulmonary medicine. Band 20, Nummer 2, März 2014, S. 173–179, doi:10.1097/MCP.0000000000000026. PMID 24384575.
  • A. Hazekamp, R. Ruhaak, L. Zuurman, J. van Gerven, R. Verpoorte: Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. In: Journal of Pharmaceutical Sciences. Band 95, Nr. 6, Juni 2006, ISSN 0022-3549, S. 1308–1317, doi:10.1002/jps.20574, PMID 16637053 (englisch).
  • Robert Melamede: Cannabis and Tobacco Smoke Are Not Equally Carcinogenic. In: Harm Reduction Journal. Band 2, 2005, Nr. 21, PMC 1277837 (freier Volltext) (englisch).
  • M. Joshi, A. Joshi, T. Bartter: Marijuana and lung diseases. In: Current opinion in pulmonary medicine. Band 20, Nr. 2, März 2014, S. 173–179, doi:10.1097/MCP.0000000000000026, PMID 24384575 (englisch, Übersichtsartikel).
  • J. R. Biehl, E. L. Burnham: Cannabis Smoking in 2015: A Concern for Lung Health? In: Chest. Band 148, Nummer 3, September 2015, S. 596–606, doi:10.1378/chest.15-0447, PMID 25996274, PMC 4556119 (freier Volltext) (Review).
  • B. Misiak, F. Stramecki, Gawęda, K. Prochwicz, M. M. Sąsiadek, A. A. Moustafa, D. Fryd: Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review. In: Molecular neurobiology. Band 55, Nummer 6, Juni 2018, S. 5075–5100, doi:10.1007/s12035-017-0708-y, PMID 28822116, PMC 5948257 (freier Volltext) (Review).
  • T. H. Moore, S. Zammit, A. Lingford-Hughes, T. R. Barnes, P. B. Jones, M. Burke, G. Lewis: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. In: Lancet. Band 370, Nummer 9584, Juli 2007, S. 319–328, doi:10.1016/S0140-6736(07)61162-3, PMID 17662880 (Review).
  • J. A. McLaren, E. Silins, D. Hutchinson, R. P. Mattick, W. Hall: Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. In: The International journal on drug policy. Band 21, Nummer 1, Januar 2010, S. 10–19, doi:10.1016/j.drugpo.2009.09.001, PMID 19783132 (Review).
  • S. Minozzi, M. Davoli, A. M. Bargagli, L. Amato, S. Vecchi, C. A. Perucci: An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. In: Drug and alcohol review. Band 29, Nummer 3, Mai 2010, S. 304–317, doi:10.1111/j.1465-3362.2009.00132.x, PMID 20565524 (Review).
  • M. Di Forti, D. Quattrone u. a.: The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. In: The lancet. Psychiatry. [elektronische Veröffentlichung vor dem Druck] März 2019, doi:10.1016/S2215-0366(19)30048-3, PMID 30902669 (freier Volltext).
  • R. Kuepper, P. D. Morrison, J. van Os, R. M. Murray, G. Kenis, C. Henquet: Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. In: Schizophrenia research. Band 121, Nummer 1–3, August 2010, S. 107–117, doi:10.1016/j.schres.2010.05.031, PMID 20580531 (Review).
  • L. Degenhardt, W. Hall, M. Lynskey: Testing hypotheses about the relationship between cannabis use and psychosis. In: Drug and alcohol dependence. Band 71, Nummer 1, Juli 2003, S. 37–48, PMID 12821204.
  • M. Rotermann, R. Macdonald: Analysis of trends in the prevalence of cannabis use in Canada, 1985 to 2015. In: Health reports. Band 29, Nummer 2, Februar 2018, S. 10–20, PMID 29465739.
  • J. Vaucher, B. J. Keating, A. M. Lasserre, W. Gan, D. M. Lyall, J. Ward, D. J. Smith, J. P. Pell, N. Sattar, G. Paré, M. V. Holmes: Cannabis use and risk of schizophrenia: a Mendelian randomization study. In: Molecular psychiatry. [elektronische Veröffentlichung vor dem Druck] Januar 2017, doi:10.1038/mp.2016.252, PMID 28115737, online (abgerufen am 4. Juli 2017).
  • J. Zheng, D. Baird, M. C. Borges, J. Bowden, G. Hemani, P. Haycock, D. M. Evans, G. D. Smith: Recent Developments in Mendelian Randomization Studies. In: Current epidemiology reports. Band 4, Nummer 4, 2017, S. 330–345, doi:10.1007/s40471-017-0128-6, PMID 29226067, PMC 5711966 (freier Volltext) (Review).
  • J. A. Pasman, K. J. Verweij u. a.: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. In: Nature Neuroscience. Band 21, Nummer 9, September 2018, S. 1161–1170, doi:10.1038/s41593-018-0206-1, PMID 30150663, PMC 6386176 (freier Volltext).
  • E. Hoch, U. Bonnet, R. Thomasius, F. Ganzer, U. Havemann-Reinecke, U. W. Preuss: Risks associated with the non-medicinal use of cannabis. In: Deutsches Ärzteblatt international. Band 112, Nr. 16, April 2015, S. 271–278, doi:10.3238/arztebl.2015.0271, PMID 25939318, PMC 4442549 (freier Volltext) – (Online-Version auf Deutsch: Risiken bei nichtmedizinischem Gebrauch von Cannabis [abgerufen am 5. Juni 2022] Übersichtsartikel).
  • I. Pacheco-Colón, J. M. Limia, R. Gonzalez: Nonacute effects of cannabis use on motivation and reward sensitivity in humans: A systematic review. In: Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. Band 32, Nummer 5, 08 2018, S. 497–507, doi:10.1037/adb0000380, PMID 29963875, PMC 6062456 (freier Volltext).
  • K. R. Hefner, M. J. Starr, J. J. Curtin: Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty. In: Journal of abnormal psychology. Band 125, Nummer 1, Januar 2016, S. 138–150, doi:10.1037/abn0000106, PMID 26595464, PMC 4701603 (freier Volltext).
  • E. van de Giessen, J. J. Weinstein, C. M. Cassidy, M. Haney, Z. Dong, R. Ghazzaoui, N. Ojeil, L. S. Kegeles, X. Xu, N. P. Vadhan, N. D. Volkow, M. Slifstein, A. Abi-Dargham: Deficits in striatal dopamine release in cannabis dependence. In: Molecular psychiatry. [elektronische Veröffentlichung vor dem Druck] März 2016, doi:10.1038/mp.2016.21, PMID 27001613.
  • K. MacDonald, K. Pappas: WHY NOT POT?: A Review of the Brain-based Risks of Cannabis. In: Innovations in clinical neuroscience. Band 13, Nummer 3–4, 2016 Mar-Apr, S. 13–22, PMID 27354924, PMC 4911936 (freier Volltext) (Review).
  • M. A. Bloomfield, A. H. Ashok, N. D. Volkow, O. D. Howes: The effects of Δ(9)-tetrahydrocannabinol on the dopamine system. In: Nature. Band 539, Nummer 7629, 11 2016, S. 369–377, doi:10.1038/nature20153, PMID 27853201, PMC 5123717 (freier Volltext) (Review).
  • Review in: M. A. Bloomfield, C. J. Morgan, A. Egerton, S. Kapur, H. V. Curran, O. D. Howes: Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. In: Biological psychiatry. Band 75, Nummer 6, März 2014, S. 470–478, doi:10.1016/j.biopsych.2013.05.027, PMID 23820822 (freier Volltext unter DOI-Link).
  • J. Jacobus, D. Goldenberg, C. E. Wierenga, N. J. Tolentino, T. T. Liu, S. F. Tapert: Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. In: Psychopharmacology. Band 222, Nummer 4, August 2012, S. 675–684, doi:10.1007/s00213-012-2674-4, PMID 22395430, PMC 3510003 (freier Volltext).
  • M. Rocchetti, A. Crescini, S. Borgwardt, E. Caverzasi, P. Politi, Z. Atakan, P. Fusar-Poli: Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. In: Psychiatry and clinical neurosciences. Band 67, Nummer 7, November 2013, S. 483–492, doi:10.1111/pcn.12085, PMID 24118193 (Review).
  • M. Maccarrone, M. Guzmán, K. Mackie, P. Doherty, T. Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature reviews. Neuroscience. Band 15, Nummer 12, Dezember 2014, S. 786–801, doi:10.1038/nrn3846, PMID 25409697 (Review).
  • P. Campolongo, V. Trezza, M. Palmery, L. Trabace, V. Cuomo: Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. In: International review of neurobiology. Band 85, 2009, S. 117–133, doi:10.1016/S0074-7742(09)85009-5, PMID 19607965 (Review).
  • S. Anavi-Goffer, J. Mulder: The polarised life of the endocannabinoid system in CNS development. In: Chembiochem: a European journal of chemical biology. Band 10, Nummer 10, Juli 2009, S. 1591–1598, doi:10.1002/cbic.200800827, PMID 19533710 (Review).
  • D. I. Lubman, A. Cheetham, M. Yücel: Cannabis and adolescent brain development. In: Pharmacology & therapeutics. Band 148, April 2015, S. 1–16, doi:10.1016/j.pharmthera.2014.11.009, PMID 25460036 (Review).
  • B. Chadwick, M. L. Miller, Y. L. Hurd: Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. In: Frontiers in psychiatry. Band 4, 2013, S. 129, doi:10.3389/fpsyt.2013.00129, PMID 24133461, PMC 3796318 (freier Volltext) (Review).
  • D. T. Malone, M. N. Hill, T. Rubino: Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. In: British journal of pharmacology. Band 160, Nummer 3, Juni 2010, S. 511–522, doi:10.1111/j.1476-5381.2010.00721.x, PMID 20590561, PMC 2931552 (freier Volltext) (Review).
  • N. Realini, T. Rubino, D. Parolaro: Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. In: Pharmacological research: the official journal of the Italian Pharmacological Society. Band 60, Nummer 2, August 2009, S. 132–138, doi:10.1016/j.phrs.2009.03.006, PMID 19559364 (Review).
  • J Hirvonen, RS Goodwin, C-T Li, GE Terry, SS Zoghbi: Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. In: Molecular Psychiatry. Band 17, Nr. 6, Juni 2012, ISSN 1359-4184, S. 642–649, doi:10.1038/mp.2011.82, PMID 21747398, PMC 3223558 (freier Volltext).
  • J. Wrege, A. Schmidt, A. Walter, R. Smieskova, K. Bendfeldt, E. W. Radue, U. E. Lang, S. Borgwardt: Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. In: Current pharmaceutical design. Band 20, Nummer 13, 2014, S. 2126–2137, PMID 23829358, PMC 4052819 (freier Volltext) (Review).
  • A. Batalla, S. Bhattacharyya, M. Yücel, P. Fusar-Poli, J. A. Crippa, S. Nogué, M. Torrens, J. Pujol, M. Farré, R. Martin-Santos: Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. In: PloS one. Band 8, Nummer 2, 2013, S. e55821, PMID 23390554, PMC 3563634 (freier Volltext) (Review).
  • S. J. Broyd, H. H. van Hell, C. Beale, M. Yücel, N. Solowij: Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. In: Biological psychiatry. Band 79, Nummer 7, April 2016, S. 557–567, doi:10.1016/j.biopsych.2015.12.002, PMID 26858214 (Review).
  • M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts, R. S. Keefe, K. McDonald, A. Ward, R. Poulton, T. E. Moffitt: Persistent cannabis users show neuropsychological decline from childhood to midlife. In: Proceedings of the National Academy of Sciences. Band 109, Nummer 40, Oktober 2012, S. E2657–E2664, doi:10.1073/pnas.1206820109, PMID 22927402, PMC 3479587 (freier Volltext).
  • T. E. Moffitt, M. H. Meier, A. Caspi, R. Poulton: Reply to Rogeberg and Daly: No evidence that socioeconomic status or personality differences confound the association between cannabis use and IQ decline. In: Proceedings of the National Academy of Sciences. Band 110, Nummer 11, März 2013, S. E980–E982, PMID 23599952, PMC 3600438 (freier Volltext).
  • J. C. Scott, S. T. Slomiak, J. D. Jones, A. F. Rosen, T. M. Moore, R. C. Gur: Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis. In: JAMA psychiatry. Band 75, Nummer 6, Juni 2018, S. 585–595, doi:10.1001/jamapsychiatry.2018.0335, PMID 29710074, PMC 6137521 (freier Volltext).
  • L. Kloft, H. Otgaar, A. Blokland, L. A. Monds, S. W. Toennes, E. F. Loftus, J. G. Ramaekers: Cannabis increases susceptibility to false memory. In: Proceedings of the National Academy of Sciences. Band 117, Nummer 9, März 2020, S. 4585–4589, doi:10.1073/pnas.1920162117, PMID 32041881, PMC 7060677 (freier Volltext).
  • J. G. Ramaekers, N. L. Mason, L. Kloft, E. L. Theunissen: The why behind the high: determinants of neurocognition during acute cannabis exposure. In: Nature reviews. Neuroscience. Band 22, Nummer 7, Juli 2021, S. 439–454, doi:10.1038/s41583-021-00466-4, PMID 34045693 (Review).
  • E. B. Oleson, J. F. Cheer: A brain on cannabinoids: the role of dopamine release in reward seeking. In: Cold Spring Harbor perspectives in medicine. Band 2, Nr. 8, 2012, S. 1–13, doi:10.1101/cshperspect.a012229, PMID 22908200, PMC 3405830 (freier Volltext) – (englisch, Übersichtsartikel).
  • E. van de Giessen, J. J. Weinstein, C. M. Cassidy, M. Haney, Z. Dong, R. Ghazzaoui, N. Ojeil, L. S. Kegeles, X. Xu, N. P. Vadhan, N. D. Volkow, M. Slifstein, A. Abi-Dargham: Deficits in striatal dopamine release in cannabis dependence. In: Molecular Psychiatry. Band 22, Nr. 1, Januar 2017, S. 68–75, doi:10.1038/mp.2016.21, PMID 27001613, PMC 5033654 (freier Volltext) – (elektronische Veröffentlichung vor dem Druck, März 2016).
  • M. L. Miller, Y. L. Hurd: Testing the Gateway Hypothesis. In: Neuropsychopharmacology. Band 42, Nummer 5, 04 2017, S. 985–986, doi:10.1038/npp.2016.279, PMID 28096528, PMC 5506797 (freier Volltext).
  • Orrin Devinsky, Maria R. Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William G. Notcutt, Jose Martinez-Orgado, Philip J. Robson, Brian G. Rohrback, Elizabeth Thiele, Benjamin Whalley, Daniel Friedman: Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. In: Epilepsia. Band 55, Nr. 6, 1. Juni 2014, S. 791–802, doi:10.1111/epi.12631, PMC 4707667 (freier Volltext).
  • C. Donath, D. Baier, E. Graessel, T. Hillemacher: Substance consumption in adolescents with and without an immigration background: a representative study—What part of an immigration background is protective against binge drinking? In: BMC Public Health. Band 16, 2016, S. 1157, doi:10.1186/s12889-016-3796-0, PMID 27842534.
  • Franziska Busse, Leyla Omidi, Alexander Leichtle, Michael Windgassen, Eyleen Kluge, Michael Stumvoll: Lead Poisoning Due to Adulterated Marijuana. In: New England Journal of Medicine. Band 358, Nr. 15, 10. April 2008, S. 1641–1642, doi:10.1056/NEJMc0707784, PMC 2696942 (freier Volltext).

pharmazeutische-zeitung.de

procon.org

marijuana.procon.org

profil.at

  • Blühen verboten: Hanfshops in Wien. In: profil.at. 7. Juli 2014 (profil.at [abgerufen am 6. März 2018]).

psychologytoday.com

radio.cz

deutsch.radio.cz

redirecter.toolforge.org

reuters.com

ru.nl

repository.ubn.ru.nl

  • G. J. Dumont, C. Kramers, F. C. Sweep, D. J. Touw, J. G. van Hasselt, M. de Kam, J. M. van Gerven, J. K. Buitelaar, R. J. Verkes: Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. In: Clinical pharmacology and therapeutics. Band 86, Nummer 2, August 2009, S. 160–166, doi:10.1038/clpt.2009.62. PMID 19440186, PDF, S. 121–138. (PDF; 2,6 MB) abgerufen am 23. Oktober 2015.

sotomo.ch

spektrum.de

spiegel.de

srf.ch

stadt-zuerich.ch

suchtmonitoring.ch

tageblatt.lu

tagesschau.de

taz.de

  • Reiner Wandler: Cannabis in Spanien: Willkommen im Kiffer-Club. In: Die Tageszeitung: taz. 13. April 2023, ISSN 0931-9085 (taz.de [abgerufen am 15. April 2023]).

thepresidency.gov.za

timesofmalta.com

tni.org

uky.edu

  • Cheryl Kaiser, Christy Cassady, Matt Ernst: Industrial Hemp Production. (PDF) In: uky.edu. University of Kentucky College of Agriculture, Food and Environment, September 2015, abgerufen am 21. Januar 2017 (PDF; 1,2 MB, englisch).

unc.edu

pdsp.unc.edu

unibe.ch

servat.unibe.ch

unodc.org

verkehrslexikon.de

wa.gov

lcb.wa.gov

washingtonpost.com

waz.de

wdr.de

www1.wdr.de

web.archive.org

weebly.com

opinionpublicaucab.weebly.com

  • Franklin Apfel: Addictions and Lifestyles in Contemporary Europe – Reframing Addictions Project;opinionpublicaucab.weebly.com (PDF; 655 kB) S. 7.

welt.de

who.int

who.int

cdn.who.int

euro.who.int

wort.lu

zdb-katalog.de

  • Ethan B. Russo, Hong-En Jiang, Xiao Li, Alan Sutton, Andrea Carboni, Francesca del Bianco, Giuseppe Mandolino, David J. Potter, You-Xing Zhao, Subir Bera, Yong-Bing Zhang, En-Guo Lü, David K. Ferguson, Francis Hueber, Liang-Cheng Zhao, Chang-Jiang Liu, Yu-Fei Wang, Cheng-Sen Li: Phytochemical and genetic analyses of ancient cannabis from Central Asia. In: Journal of Experimental Botany. Band 59, Nr. 15, 1. November 2008, ISSN 0022-0957, S. 4171–4182, doi:10.1093/jxb/ern260 (englisch).
  • C. A. Paronis, S. P. Nikas, V. G. Shukla, A. Makriyannis: Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. In: Behavioural pharmacology. Band 23, Nummer 8, Dezember 2012, S. 802–805, ISSN 1473-5849. doi:10.1097/FBP.0b013e32835a7c4d. PMID 23075707. PMC 3697741 (freier Volltext).
  • Mauro Maccarrone, Manuel Guzmán, Ken Mackie, Patrick Doherty, Tibor Harkany: Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. In: Nature Reviews Neuroscience. Band 15, Nr. 12, Dezember 2014, ISSN 1471-003X, S. 786–801, doi:10.1038/nrn3846, PMID 25409697, PMC 4765324 (freier Volltext) – (nature.com [abgerufen am 3. August 2022]).
  • Miriam Schneider: Adolescence as a vulnerable period to alter rodent behavior. In: Cell and Tissue Research. Band 354, Nr. 1, Oktober 2013, ISSN 0302-766X, S. 99–106, doi:10.1007/s00441-013-1581-2.
  • Heidi C. Meyer, Francis S. Lee, Dylan G. Gee: The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. In: Neuropsychopharmacology. Band 43, Nr. 1, Januar 2018, ISSN 0893-133X, S. 21–33, doi:10.1038/npp.2017.143, PMID 28685756, PMC 5719094 (freier Volltext).
  • Tibor Wenger, Dominique Croix, Gerard Tramu: The Effect of Chronic Prepubertal Administration of Marihuana (Delta-9-Tetrahydrocannabinol) on the Onset of Puberty and the Postpubertal Reproductive Functions in Female Rats. In: Biology of Reproduction. Band 39, Nr. 3, 1. Oktober 1988, ISSN 0006-3363, S. 540–545, doi:10.1095/biolreprod39.3.540.
  • Matthias Klugmann, Viktoria Klippenstein, F. Markus Leweke, Rainer Spanagel, Miriam Schneider: Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels. In: The International Journal of Neuropsychopharmacology. Band 14, Nr. 04, Mai 2011, ISSN 1461-1457, S. 505–517, doi:10.1017/S1461145710001562.
  • Russell C. Callaghan, Peter Allebeck, Anna Sidorchuk: Marijuana use and risk of lung cancer: a 40-year cohort study. In: Cancer Causes & Control. Band 24, Nr. 10, Oktober 2013, ISSN 0957-5243, S. 1811–1820, doi:10.1007/s10552-013-0259-0.
  • A. Hazekamp, R. Ruhaak, L. Zuurman, J. van Gerven, R. Verpoorte: Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. In: Journal of Pharmaceutical Sciences. Band 95, Nr. 6, Juni 2006, ISSN 0022-3549, S. 1308–1317, doi:10.1002/jps.20574, PMID 16637053 (englisch).
  • J Hirvonen, RS Goodwin, C-T Li, GE Terry, SS Zoghbi: Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. In: Molecular Psychiatry. Band 17, Nr. 6, Juni 2012, ISSN 1359-4184, S. 642–649, doi:10.1038/mp.2011.82, PMID 21747398, PMC 3223558 (freier Volltext).
  • D. R. ENGLISH, G. K. HULSE, E. MILNE, C. D. J. HOLMAN, C. I. BOWER: Maternal cannabis use and birth weight: a meta-analysis. In: Addiction. Band 92, Nr. 11, November 1997, ISSN 0965-2140, S. 1553–1560, doi:10.1111/j.1360-0443.1997.tb02875.x.
  • Shalem Y. Leemaqz, Gustaaf A. Dekker, Lesley M. McCowan, Louise C. Kenny, Jenny E. Myers: Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. In: Reproductive Toxicology. Band 62, Juli 2016, ISSN 0890-6238, S. 77–86, doi:10.1016/j.reprotox.2016.04.021.
  • Albert Stuart Reece: Chronic toxicology of cannabis. In: Clinical Toxicology. Band 47, Nr. 6, Juli 2009, ISSN 1556-3650, S. 517–524, doi:10.1080/15563650903074507.
  • Tina Birk Irner: Substance exposure in utero and developmental consequences in adolescence: A systematic review. In: Child Neuropsychology. Band 18, Nr. 6, November 2012, ISSN 0929-7049, S. 521–549, doi:10.1080/09297049.2011.628309.
  • Justin H. G. Williams, Louise Ross: Consequences of prenatal toxin exposure for mental health in children and adolescents: A systematic review. In: European Child & Adolescent Psychiatry. Band 16, Nr. 4, Juni 2007, ISSN 1018-8827, S. 243–253, doi:10.1007/s00787-006-0596-6.
  • Birgit Großekathöfer, Fabian Pieper: Cannabis-Legalisierung kommt: Wie steht es um das deutsche Gras? In: Der Spiegel. 20. November 2021, ISSN 2195-1349 (spiegel.de [abgerufen am 20. November 2021]).
  • Uno-Drogenbericht: Cannabis-Konsum belastet Gesundheitssysteme. In: Der Spiegel. 27. Juni 2022, ISSN 2195-1349 (spiegel.de [abgerufen am 27. Juni 2022]).
  • Cannabis-Legalisierung: Kommission schlägt THC-Grenzwert für sicheres Fahren vor. In: Der Spiegel. 28. März 2024, ISSN 2195-1349 (spiegel.de [abgerufen am 28. März 2024]).
  • Reiner Wandler: Cannabis in Spanien: Willkommen im Kiffer-Club. In: Die Tageszeitung: taz. 13. April 2023, ISSN 0931-9085 (taz.de [abgerufen am 15. April 2023]).
  • Legalisierung von Marihuana: Uruguay startet freien Cannabis-Verkauf. In: Die Zeit. 19. Juli 2017, ISSN 0044-2070 (zeit.de [abgerufen am 10. April 2018]).

zdf.de

zeit.de